Teza Capital Management LLC Biogen Inc. Transaction History

Teza Capital Management LLC

$809 Million
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $350,681 - $442,792	1,654 New	1,654 $356,000
Q3 2023 Feb 22, 2024	BUY	$253.3 - $285.89 $2.24 Million - $2.52 Million	8,832 Added 482.1%	10,664 $2.74 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $3.03 Million - $3.42 Million	11,965 Added 401.51%	14,945 $3.84 Million
Q2 2023 Feb 22, 2024	BUY	$275.25 - $318.06 $504,258 - $582,685	1,832 New	1,832 $521,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $820,245 - $947,818	2,980 New	2,980 $848,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $986,535 - $1.2 Million	3,908 Added 93.81%	8,074 $2.24 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $811,078 - $1.12 Million	4,166 New	4,166 $1.11 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.09 Million - $1.3 Million	-5,817 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.13 Million - $1.42 Million	5,817 New	5,817 $1.23 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $558,680 - $717,986	-2,495 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $1.39 Million - $1.82 Million	-4,922 Reduced 66.36%	2,495 $706,000
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $1.92 Million - $3.08 Million	7,417 New	7,417 $2.57 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $507,765 - $594,876	-2,090 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $493,783 - $743,266	2,090 New	2,090 $512,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1.75 Million - $2.02 Million	-6,604 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $1.71 Million - $2.26 Million	6,604 New	6,604 $1.77 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $890,700 - $1.13 Million	-3,313 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $292,459 - $404,109	-1,329 Reduced 28.63%	3,313 $983,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.01 Million - $1.13 Million	4,642 New	4,642 $1.08 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $1.02 Million - $1.33 Million	-3,468 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $65,925 - $78,568	-256 Reduced 6.87%	3,468 $1.01 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $213,046 - $301,318	819 Added 28.19%	3,724 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $893,694 - $1 Million	2,905	2,905 $925,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.08 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.03 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.7 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.32 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.05 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Account